Westwood Holdings Group Inc. Reduces Stock Position in GRAIL, Inc. $GRAL

Westwood Holdings Group Inc. lowered its stake in GRAIL, Inc. (NASDAQ:GRAL) by 46.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,475 shares of the company’s stock after selling 15,109 shares during the period. Westwood Holdings Group Inc.’s holdings in GRAIL were worth $899,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in GRAL. Farther Finance Advisors LLC raised its holdings in GRAIL by 768.1% in the second quarter. Farther Finance Advisors LLC now owns 816 shares of the company’s stock worth $42,000 after purchasing an additional 722 shares in the last quarter. NewEdge Advisors LLC grew its position in shares of GRAIL by 390.3% in the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock worth $45,000 after buying an additional 1,401 shares during the period. Quarry LP increased its stake in shares of GRAIL by 1,965.4% in the 1st quarter. Quarry LP now owns 2,148 shares of the company’s stock worth $55,000 after acquiring an additional 2,044 shares in the last quarter. Roble Belko & Company Inc purchased a new position in GRAIL during the 2nd quarter valued at about $68,000. Finally, Cypress Capital Management LLC WY bought a new stake in GRAIL during the second quarter worth about $72,000.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on GRAL shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Canaccord Genuity Group raised their price objective on GRAIL from $85.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, November 17th. UBS Group set a $75.00 target price on GRAIL in a report on Friday, October 3rd. Guggenheim upgraded GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, November 12th. Finally, Morgan Stanley lifted their price target on GRAIL from $85.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Monday, December 1st. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $97.50.

GRAIL Stock Performance

Shares of NASDAQ:GRAL opened at $91.04 on Tuesday. The firm has a market cap of $3.55 billion, a price-to-earnings ratio of -7.83 and a beta of 4.23. The business has a 50-day simple moving average of $88.10 and a two-hundred day simple moving average of $57.29. GRAIL, Inc. has a fifty-two week low of $16.10 and a fifty-two week high of $115.76.

GRAIL (NASDAQ:GRAL) last issued its earnings results on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.40) by $0.94. GRAIL had a negative net margin of 286.43% and a negative return on equity of 15.69%. The company had revenue of $36.19 million for the quarter, compared to analysts’ expectations of $33.83 million. As a group, research analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Buying and Selling at GRAIL

In other GRAIL news, CEO Robert P. Ragusa sold 7,239 shares of the company’s stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total value of $498,622.32. Following the completion of the sale, the chief executive officer owned 727,388 shares in the company, valued at $50,102,485.44. This represents a 0.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Joshua J. Ofman sold 6,114 shares of the stock in a transaction that occurred on Thursday, October 16th. The stock was sold at an average price of $82.01, for a total transaction of $501,409.14. Following the completion of the sale, the president directly owned 381,818 shares of the company’s stock, valued at $31,312,894.18. This represents a 1.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 113,295 shares of company stock valued at $7,380,888 over the last 90 days. 1.85% of the stock is currently owned by company insiders.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.